BCEL

Atreca Inc
1.19
0.00 (0.0%)

Atreca Inc. (BCEL) Fundamentals

Atreca Inc is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types. The company's product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism of action and target derived from an antibody identified using its discovery platform.
SHARE INFORMATION
Market CapUS$ 48,834,239
Shares Outstanding39,067,391
Float27,757,605
Percent Float71.05%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0.00
Latest Fiscal RevenueUS$ 0
Latest Fiscal EPSUS$ -2.95
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)US$ 0.00
Dividend (5 Years)US$ 0.00
Ex Dividend Date-
Dividend RateUS$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions191
Institutional Holdings Date2023-02-28
Institutional Bought Previous 3 Months88,895
Institutional Holdings Percent49.0%
Institutional Sold Previous 3 Months3,943,736
Insider Holdings Date2023-02-28
Insider Bought Previous 3 Months1,503,750
Insider Holdings Percent3.0
Insider Sold Previous 3 Months43,750
Insider Shares Owned1,169,087
TRADING INFO
52 Week HighUS$ 3.92
52 Week LowUS$ 0.76
52 Week High ChangeUS$ -63.02
21 Day Moving AverageUS$ 1.404
21 Day Extended Moving AverageUS$ 1.3948
50 Day Moving AverageUS$ 1.5243
50 Day Extended Moving AverageUS$ 1.422
200 Day Moving AverageUS$ 1.6344
200 Day Extended Moving AverageUS$ 1.8497
10 Day Average Volume93,983
20 Day Average Volume132,600
30 Day Average Volume123,019
50 Day Average Volume155,200
Alpha-0.026561
Beta1.1225
Standard Deviation0.310434
R20.041541
7 Day Price ChangeUS$ -0.08
7 Day Percent Change-6.02%
21 Day Price ChangeUS$ 0.00
21 Day Percent Change0.0%
30 Day Price ChangeUS$ -0.34
30 Day Percent Change-21.38%
Month to Date Price ChangeUS$ -0.18
Month to Date Percent Change-12.59%
Quarter to Date Price ChangeUS$ 0.4494
Quarter to Date Percent Change56.13%
180 Day Price ChangeUS$ -0.43
180 Day Percent Change-25.6%
200 Day Price ChangeUS$ -0.53
200 Day Percent Change-29.78%
Year to Date Price ChangeUS$ 0.4494
Year to Date Percent Change56.13%

Atreca Inc. (BCEL) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
RevenueUS$ 0
Revenue Per ShareUS$ 0.00
Revenue (3 Years)US$ 0.00
Revenue (5 Years)US$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.50
Total Debt To Equity0.70
Int Coverage-109,628.00
Current Ratio6.40
Leverage Ratio1.70
Quick Ratio6.10
Long Term Debt To Capital0.39
VALUATION MEASURES
PE Ratio4.50
Enterprise ValueUS$ 28,967,260
Price to Sales0.00
Price to Free Cash-0.80
PE High Last 5 Years0.00
Price To Book0.50
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book0.50
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-58.73
Return on Equity-86.03
Return on Capital-52.75

Atreca Inc. (BCEL) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorWithumSmith+Brown, PC
CEOJohn A. Orwin
Emplyoees91
Last AuditUE
CIK0001532346
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address835 Industrial Road
Suite 400
San Carlos, CA 94070
Websitehttps://www.atreca.com
Facsimile+1 650 453-2410
Telephone+1 650 595-2595
Email-
Your Recent History
NASDAQ
BCEL
Atreca
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:au D:20230324 10:09:07